Eight Hyped Compounds Failed to Extend Lifespan in a Major Mouse Study

Strong Evidence·Animal Study·GeroScience·Mar 2026

The NIA's Interventions Testing Program tested eight compounds across three lab sites in genetically diverse mice. None extended lifespan. That includes astaxanthin, alpha-ketoglutarate, pioglitazone, atorvastatin-telmisartan, and others with prior promising results. Some compounds previously shown to work at different doses or start ages didn't replicate under new conditions. Two drugs actually shortened lifespan in female mice.

Key Insight

This study suggests that dose and timing matter enormously, and early lifespan results in mice often don't hold up.

Original Paper

GeroScience··UM-HET3 mice across three sites (exact N not specified)

Related Studies

Quail Bred to Reproduce More Aged Faster, Supporting a Core Theory of Aging

Researchers selectively bred Japanese quail for higher or lower reproductive effort across several generations. By generations five and six, the high-reproduction birds died sooner. The lifespan difference came from faster aging rates, not from being more fragile to begin with. This is some of the cleanest experimental evidence in vertebrates that investing more in reproduction comes at a real cost to longevity.

Proceedings. Biological sciences·Moderate·Apr 14, 2026

We May Not Be Aging Slower. We're Just Starting Later.

A big question in longevity research is whether rising life expectancy means we're actually aging more slowly. This analysis of mortality data from 12 countries suggests the answer is no. After accounting for historical shocks like wars and pandemics, the rate at which aging accelerates after 80 hasn't changed. The gains in lifespan appear to come from pushing back when serious aging begins, not from slowing the process itself.

Proceedings of the National Academy of Sciences of the United States of America·Moderate·Apr 8, 2026

Metformin's Anti-Aging Case: Strong Clues but Still No Proof

This review pulls together lab, population, and clinical trial evidence on metformin as a potential aging-slowing drug. At normal doses, metformin seems to flip several key aging switches: boosting cellular cleanup, calming inflammation, and improving energy production. Large population studies link metformin use to lower rates of age-related diseases, even in people without diabetes. However, the review honestly notes that metformin may actually worsen aging in older animals, so the picture is still mixed.

Molecular and cellular endocrinology·Moderate·Apr 3, 2026

Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.